Honourable guests witnessing this significant event included Prof. Jin-Guang TENG, President of PolyU (4th from left), Prof. Christopher CHAO, Vice President (Research and Innovation) (3rd from left), Prof. David SHUM, Dean of Faculty of Health and Social Sciences (2nd from left), Prof. Mingguang HE, Director of Research Centre for SHARP Vision; Director of the PolyU-Rohto Centre of Research Excellence for Eye Care and Chair Professor of Experimental Ophthalmology School of Optometry (1st from left), Mr Michael SIN, President of Mentholatum Asia Pacific (4th from right), and Mr Wesley CHAN, General Manager of Sales and Marketing, Mentholatum (China) Pharmaceutical Co., Ltd (3rd from right), Ms Teresa WONG, General Manager of Sales and Marketing of Mentholatum Hong Kong and Macau (2nd from right), and Mr Patrick MOK, General Manager (Production) of Mentholatum (China) Pharmaceuticals Co., Ltd (1st from right).
PolyU and Rohto jointly released the “Promoting Healthy Vision and Prioritizing Standardised Diagnosis of Eye Fatigue” advocacy paper, which aims to enhance eye health within the broader community."
The Hong Kong Polytechnic University (PolyU) partnered with Rohto, an eye care brand under Mentholatum, to establish the PolyU-Rohto Centre of Research Excellence for Eye Care (“the Centre”). The Centre’s inauguration took place at the “Leading Research in Eye Fatigue, Empowering the Joy of Seeing” launch ceremony held in Hong Kong. During the event, PolyU and Rohto also jointly released the “Promoting Healthy Vision and Prioritizing Standardised Diagnosis of Eye Fatigue” advocacy paper, which aims to enhance eye health within the broader community.
Honourable guests witnessing this significant event included Prof. Jin-Guang TENG, President of PolyU, Prof. Christopher CHAO, Vice President (Research and Innovation), Prof. ZuanKai WANG, Associate Vice President (Research and Innovation), Prof. David SHUM, Dean of Faculty of Health and Social Sciences, Prof. Mingguang HE, Director of Research Centre for SHARP Vision; Director of the PolyU-Rohto Centre of Research Excellence for Eye Care and Chair Professor of Experimental Ophthalmology School of Optometry, Mr Michael SIN, President of Mentholatum Asia Pacific, and Mr Wesley CHAN, General Manager of Sales and Marketing, Mentholatum (China) Pharmaceutical Co., Ltd.
Establishment of The PolyU-Rohto Centre of Research Excellence for Eye Care marks a breakthrough for the optometry industry
At the launch ceremony, Prof. Teng, said, "The University's School of Optometry is one of the world's leading institutions in optometry and vision science, and PolyU is the only university in Hong Kong offering optometry education. We have established several research centres related to ophthalmology, including the Centre for Eye and Vision Research launched with the University of Waterloo in Canada and supported by the HKSAR Government, as well as the Centre for Vision Science Research under the PolyU Academy for Interdisciplinary Research. The partnership with Rohto represents a powerful alliance in eye care."
Moving forward, the Centre will gather teams of ophthalmic experts to conduct research and testing in multiple locations and establish collaborative networks with various regions to develop eye health and care technologies, aiming to provide comprehensive medical and care solutions for eye fatigue.
Early attention is crucial in the face of rising eye fatigue cases
Prof. Mingguang He, Director of Research Centre for SHARP Vision; Director of the PolyU-Rohto Centre of Research Excellence for Eye Care and renowned scholar in the international optometry field, corroborated these findings at the launch ceremony, stating “Due to society’s digital transformation and fast-paced lifestyles, eye-fatigue problems are increasingly prevalent. This problem can significantly impact both quality of life and work efficiency, but the majority of people tend to overlook its significance.”
Prof. Mingguang He also noted that eye fatigue is caused by prolonged eye usage, leading to tiredness and discomfort. It already affects approximately 20-30% of children and adolescents and 50-80% of adults, including university students and office workers who use computers extensively. However, the establishment of an innovative and standardised treatment system for eye fatigue is still a work in progress. Currently, the traditional diagnosis of eye fatigue relies heavily on subjective questionnaires, while treatment methods vary, lacking a unified objective diagnostic standard and evaluation. As a result, eye fatigue is often overlooked by patients and clinical practitioners, leading to a relatively limited understanding of this condition in terms of both public awareness and academic research. It is crucial to prioritise high-quality research into and resolution of eye fatigue issues.
Rohto partners with PolyU to introduce Eye Fatigue advocacy: Enhancing public eye health in four key areas
The low level of public awareness of eye fatigue and the existing diagnosis system being ill-prepared to effectively tackle this issue are of growing concern. Mr Michael Sin, President of Mentholatum Asia Pacific, said, "Mentholatum holds a strong commitment to scientific research, grounding its practices in scientific principles and relying on experimental evidence. It prides itself on introducing products of the highest quality. The Rohto brand is recognised as the world's leading eye-care brand. Over the years, Mentholatum has been dedicated to promoting eye health, particularly through the development and introduction of a range of eye drops targeting eye fatigue. We are honoured to collaborate with The Hong Kong Polytechnic University in establishing the PolyU-Rohto Centre of Research Excellence for Eye Care. We share a common vision in promoting research into eye fatigue, recruiting talented individuals, and focusing on the study of eye-fatigue technology to aid in treatment and alleviate the impact of eye fatigue, allowing us to appreciate the world with our eyes to the fullest.” On this occasion, Rohto and PolyU also jointly announced the launch of the "Promoting Healthy Vision and Prioritizing Standardised Diagnosis of Eye Fatigue" advocacy paper."
This advocacy, centred around the "Know-Diagnose-Explore-Engage" framework, aims to enhance public awareness of eye fatigue. Its objectives are to establish and promote globally unified diagnostic standards and develop a multi-level diagnosis system. It also seeks to explore new prevention methods and treatment approaches. Through collaboration with various sectors, the Centre is dedicated to creating a healthy environment for eye health, cultivating healthy eye habits, and mitigating the impact of visual fatigue on public eye health, thereby improving individuals' quality of life.
